FDA Approves Tezspire for Self-Administration With New Prefilled Pen
The new prefilled, single-use pen is provided as 210mg/1.91mL (110mg/mL) for subcutaneous injection into the thigh or abdomen.
Diagnosis & Disease Information
January 2023 Recap: Drug Pipeline Updates
The table provided is a review of notable updates that occurred in January 2023 for investigational products in development.
Belimumab Granted Orphan Drug Status for Systemic Sclerosis
Belimumab is a B-lymphocyte stimulator-specific inhibitor.
MPR Weekly Dose Podcast #145
Pfizer-BioNTech bivalent vaccine under investigation; Trial evaluating HIV prevention vaccine discontinued; Early detection sepsis test cleared; Trial results for RSV-associated disease vaccine; Combo Tx for HCC recurrence shows promise.
Frequent Green Space Visits Linked to Lower Use of Certain Meds
Lower use of psychotropic, antihypertensive, and asthma medications observed; association attenuated by body mass index
Moderna’s mRNA Vaccine Candidate Prevents RSV-Associated Disease in Older Adults
Results showed vaccine efficacy of 83.7% against RSV-LRTD, defined by 2 or more symptoms.
Fixed-Dose Combo Airsupra Approved as Rescue Therapy for Asthma
Airsupra is a first-in-class, pressurized metered dose inhaler, fixed-dose combination of albuterol and budesonide.
FDA to Review 20-Valent Pneumococcal Conjugate Vaccine for Pediatric Use
The 20vPnC vaccine consists of capsular polysaccharide conjugates for the 13 serotypes included in Prevnar 13, along with 7 additional serotypes that cause invasive pneumococcal disease.
Nirsevimab Under Review for Protection Against RSV for All Infants
Nirsevimab is a long-acting anti-RSV for nirsevimab for the prevention of RSV lower.
